Biotechnology development
Search documents
AbCellera Biologics Inc. (ABCL) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript
Seeking Alpha· 2026-01-15 02:16
Company Overview - AbCellera is a biotechnology company headquartered in Vancouver, Canada, with approximately 500 employees, and additional facilities in Sydney, Australia, and a clinical development group in Montreal, Canada [3] - The company was founded in 2012 from an academic lab at the University of British Columbia [3] Leadership and Future Outlook - CEO Carl Hansen provided insights into the company's growth and future potential, emphasizing a transition from a technology and platform-based focus to a clinical company with multiple assets [2] - The next 6 to 18 months are expected to be significant for the company, with upcoming developments in their portfolio and promising readouts [2]